Kodiak Sciences Inc (KOD) Stock Price, Quote & News

Company Profile

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degenerati...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 281 0850

Website: kodiak.com

Address:

1250 Page Mill Road, Palo Alto, United States

Cutlass Apr. 28 at 3:43 PM

$KOD So resilient 👀 👍

0 · Reply

Stekli27 Apr. 24 at 2:14 PM

$KOD Shaky shaky.. but no big sellers? 🤔 someone’s getting their shares cheap 🫣

0 · Reply

Cutlass Apr. 24 at 1:23 PM

$KOD 👀🟢

0 · Reply

Whiskeyunderthebed Apr. 24 at 1:05 PM

$KOD My PC color scheme seems to be back...

0 · Reply

John_Smithh Apr. 24 at 11:50 AM

$KOD $70 is like your neighbor - just around the corner 🍀

0 · Reply

Bazzzigar Apr. 23 at 9:37 PM

$KOD ALNY

0 · Reply

Stekli27 Apr. 23 at 2:51 PM

$KOD Healthy pullback after a strong run. Biotech is red across the board today. Could be a good spot for accumulation if momentum holds.

0 · Reply

Whiskeyunderthebed Apr. 23 at 2:40 PM

$KOD My OLED screen must be going on my PC- it looks red today?

0 · Reply

Whiskeyunderthebed Apr. 22 at 8:05 PM

$KOD what happened?

0 · Reply

Whiskeyunderthebed Apr. 22 at 1:11 PM

$KOD what's new it's green again...

0 · Reply

Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers

AEHR BZAI FBYD IWM SATL

Mar 31, 2026, 4:45 PM EDT - 4 weeks ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Mar 30, 2026, 10:00 AM EDT - 4 weeks ago

Kodiak Sciences: Road To $120

Mar 27, 2026, 10:40 AM EDT - 4 weeks ago

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Mar 26, 2026, 12:33 PM EDT - 4 weeks ago

Kodiak Sciences stock soars over 60%: what's behind the sharp rally

Mar 26, 2026, 8:12 AM EDT - 4 weeks ago

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

Mar 26, 2026, 6:00 AM EDT - 4 weeks ago

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Feb 4, 2026, 7:00 AM EST - 3 months ago

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

Jan 22, 2026, 10:26 AM EST - 3 months ago

These 20 stocks are strong choices for momentum investors

BE CELC COGT FBYD FRGE INBX LITE

Jan 12, 2026, 4:30 PM EST - 3 months ago

Kodiak Sciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:19 PM EST - 3 months ago

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 8:26 PM EST - 4 months ago

Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dec 16, 2025, 10:55 PM EST - 4 months ago

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

Dec 15, 2025, 4:01 PM EST - 4 months ago

Kodiak Sciences Announces Proposed Public Offering of Common Stock

Dec 3, 2025, 3:00 PM EST - 5 months ago

Kodiak Sciences Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 17, 2025, 11:30 AM EST - 5 months ago

Kodiak Sciences Transcript: Jefferies London Healthcare Conference 2025

Nov 13, 2025, 4:05 PM EST - 5 months ago

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Nov 12, 2025, 5:48 PM EST - 5 months ago

Kodiak Sciences to Present at Upcoming Investor Conferences

Nov 5, 2025, 7:00 AM EST - 6 months ago

Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)

Oct 31, 2025, 12:01 PM EDT - 6 months ago

The Big 3: GOOGL, KOD, FTK

GOOG GOOGL FTK

Sep 15, 2025, 7:00 AM EDT - 8 months ago

New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

Sep 2, 2025, 8:00 AM EDT - 8 months ago

Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)

Aug 27, 2025, 10:40 AM EDT - 8 months ago

Harbour BioMed Reports 2025 Interim Results

Aug 27, 2025, 6:54 AM EDT - 8 months ago

Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock

Aug 19, 2025, 2:18 PM EDT - 9 months ago

Kodiak Sciences to Present at American Chemical Society Fall 2025

Aug 13, 2025, 4:00 PM EDT - 9 months ago

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results

Jul 16, 2025, 1:00 PM EDT - 10 months ago

Kodiak Sciences Transcript: R&D Day 2025

Jul 10, 2025, 8:00 AM EDT - 10 months ago

Kodiak Sciences to Host Investor R&D Day on July 16, 2025

Jun 25, 2025, 4:45 PM EDT - 10 months ago

Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society

Jun 5, 2025, 9:20 AM EDT - 11 months ago

Kodiak Sciences Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 9:32 PM EDT - 11 months ago

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference

May 14, 2025, 4:15 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results

May 1, 2025, 11:43 PM EDT - 1 year ago

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Mar 10, 2025, 4:39 PM EDT - 1 year ago

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Feb 4, 2025, 7:30 AM EST - 1 year ago

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Kodiak Sciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 7, 2025, 6:00 AM EST - 1 year ago

Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 9, 2024, 12:33 PM EST - 1 year ago

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock

Dec 3, 2024, 2:35 PM EST - 1 year ago

Kodiak Sciences Transcript: 7th Annual Evercore ISI HealthCONx Conference

Nov 21, 2024, 4:00 AM EST - 1 year ago

Kodiak Sciences Transcript: Jefferies London Healthcare Conference 2024

Nov 14, 2024, 4:01 PM EST - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Nov 11, 2024, 6:15 AM EST - 1 year ago

Kodiak Sciences to Participate in Upcoming Investor Conferences

Oct 14, 2024, 5:35 PM EDT - 1 year ago

Kodiak Sciences to Present at Innovate Retina 2024

Sep 23, 2024, 10:30 AM EDT - 1 year ago

Kodiak Sciences Transcript: R&D Day 2024

Sep 23, 2024, 6:00 AM EDT - 1 year ago

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

Sep 17, 2024, 4:05 PM EDT - 1 year ago

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results

Jun 13, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 6, 2024, 8:00 AM EDT - 2 years ago

Kodiak Sciences Transcript: Jefferies 2024 Global Healthcare Conference

May 29, 2024, 4:36 PM EDT - 2 years ago

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

May 15, 2024, 4:01 PM EDT - 2 years ago

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

May 13, 2024, 7:32 PM EDT - 2 years ago

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

May 2, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Kodiak Sciences Earnings Call Transcript: Q4 2023

Mar 28, 2024, 6:30 AM EDT - 2 years ago

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 6:15 AM EDT - 2 years ago

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

Jan 30, 2024, 6:30 AM EST - 2 years ago

Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting

Jan 4, 2024, 4:15 PM EST - 2 years ago

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 21, 2023, 4:15 PM EST - 2 years ago

Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Nov 14, 2023, 4:01 PM EST - 2 years ago

Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 6, 2023, 5:00 AM EST - 2 years ago

Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission

Cutlass Apr. 28 at 3:43 PM

$KOD So resilient 👀 👍

0 · Reply

Stekli27 Apr. 24 at 2:14 PM

$KOD Shaky shaky.. but no big sellers? 🤔 someone’s getting their shares cheap 🫣

0 · Reply

Cutlass Apr. 24 at 1:23 PM

$KOD 👀🟢

0 · Reply

Whiskeyunderthebed Apr. 24 at 1:05 PM

$KOD My PC color scheme seems to be back...

0 · Reply

John_Smithh Apr. 24 at 11:50 AM

$KOD $70 is like your neighbor - just around the corner 🍀

0 · Reply

Bazzzigar Apr. 23 at 9:37 PM

$KOD ALNY

0 · Reply

Stekli27 Apr. 23 at 2:51 PM

$KOD Healthy pullback after a strong run. Biotech is red across the board today. Could be a good spot for accumulation if momentum holds.

0 · Reply

Whiskeyunderthebed Apr. 23 at 2:40 PM

$KOD My OLED screen must be going on my PC- it looks red today?

0 · Reply

Whiskeyunderthebed Apr. 22 at 8:05 PM

$KOD what happened?

0 · Reply

Whiskeyunderthebed Apr. 22 at 1:11 PM

$KOD what's new it's green again...

0 · Reply

Whiskeyunderthebed Apr. 21 at 4:13 PM

$KOD this is green everyday!

0 · Reply

Stekli27 Apr. 21 at 3:20 PM

$KOD clean VWAP test after the push. Price holding ~46 while large inflow stays strong, looks like accumulation, not distribution. If this holds and reclaims 46.6–47 with volume, 50 comes fast. Quiet build under resistance 👀

0 · Reply

mikesterz7 Apr. 21 at 8:59 AM

$KOD wait for more news 🔥

0 · Reply

Darimartin Apr. 21 at 8:53 AM

$KOD I have them at $3 and I'm getting really dizzy. Could this be worth 3 billion and not have a single product on the market? We all know it takes money to bring a drug to market. I'm really scared of dilution. What do you think? Excuse my English.

2 · Reply

JFalktrader Apr. 21 at 8:30 AM

$ENSC “The bio sector is heating up — several biotechs are leading the pre‑market with strong moves and rising volume. $SPRC $BIYA $ASBP and $KOD show clear momentum, and sentiment is shifting back toward biotech. Strong sector pressure right now — let’s see when ENSC gets its turn.

0 · Reply